Literature DB >> 18946892

Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines -- Heart Failure Program study.

Uptal D Patel1, Adrian F Hernandez, Li Liang, Eric D Peterson, Kenneth A LaBresh, Clyde W Yancy, Nancy M Albert, Gray Ellrodt, Gregg C Fonarow.   

Abstract

BACKGROUND: Both heart failure (HF) and chronic kidney disease (CKD) are highly prevalent conditions that often coexist; however, the quality of care received by hospitalized patients with both is not known.
METHODS: The Get With the Guidelines - HF registry and performance improvement program prospectively collects data on patients hospitalized with HF. Performance measures to improve treatment of patients with HF and inhospital mortality were examined by kidney function based on glomerular filtration rate (GFR) categorized as normal (GFR > or = 90), mild (60 < or = GFR < 90), moderate (30 < or = GFR < 60), severe (15 < or = GFR < 30), and kidney failure (GFR < 15 or dialysis).
RESULTS: Nearly two thirds of hospitalized patients with HF (15,560 patients from 137 hospitals) also had CKD: moderate CKD (43.9%), severe CKD (14.2%), and kidney failure (6.6%). Inpatient mortality was higher for patients with more severe renal dysfunction. Those with kidney failure were significantly less likely to receive nearly all guidelines-based therapies. In contrast, those with moderate or severe CKD often received similar care when compared with those with normal kidney function, except for lower use of angiotensin-converting enzyme inhibitors or receptor blockers (odds ratio 0.19 [0.13-0.28] and 0.47 [0.36-0.62], respectively) and lower proportions with blood pressure control (odds ratio 0.70 [0.58-0.85] and 0.52 [0.42-0.63], respectively).
CONCLUSIONS: In a large contemporary cohort of patients hospitalized with HF, we found that renal dysfunction was a highly prevalent comorbidity. Despite higher mortality rates, patients with increased severity of renal dysfunction were less likely to receive important guideline-recommended therapies. Further efforts are needed to improve the care of patients with HF and CKD.

Entities:  

Mesh:

Year:  2008        PMID: 18946892      PMCID: PMC2604122          DOI: 10.1016/j.ahj.2008.05.028

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  18 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  The quality of health care delivered to adults in the United States.

Authors:  Elizabeth A McGlynn; Steven M Asch; John Adams; Joan Keesey; Jennifer Hicks; Alison DeCristofaro; Eve A Kerr
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

3.  ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America.

Authors:  Robert O Bonow; Susan Bennett; Donald E Casey; Theodore G Ganiats; Mark A Hlatky; Marvin A Konstam; Costas T Lambrew; Sharon-Lise T Normand; Ileana L Piña; Martha J Radford; Andrew L Smith; Lynne Warner Stevenson; Robert O Bonow; Susan J Bennett; Gregory Burke; Kim A Eagle; Harlan M Krumholz; Costas T Lambrew; Jane Linderbaum; Frederick A Masoudi; Sharon-Lise T Normand; James L Ritchie; John S Rumsfeld; John A Spertus
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

4.  Risk-treatment mismatch in the pharmacotherapy of heart failure.

Authors:  Douglas S Lee; Jack V Tu; David N Juurlink; David A Alter; Dennis T Ko; Peter C Austin; Alice Chong; Therese A Stukel; Daniel Levy; Andreas Laupacis
Journal:  JAMA       Date:  2005-09-14       Impact factor: 56.272

5.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2005-09-13       Impact factor: 29.690

6.  The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.

Authors:  Justin Ezekowitz; Finlay A McAlister; Karin H Humphries; Colleen M Norris; Marcello Tonelli; William A Ghali; Merril L Knudtson
Journal:  J Am Coll Cardiol       Date:  2004-10-19       Impact factor: 24.094

7.  Trends in heart failure incidence and survival in a community-based population.

Authors:  Véronique L Roger; Susan A Weston; Margaret M Redfield; Jens P Hellermann-Homan; Jill Killian; Barbara P Yawn; Steven J Jacobsen
Journal:  JAMA       Date:  2004-07-21       Impact factor: 56.272

8.  Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study.

Authors:  Finlay A McAlister; Justin Ezekowitz; Marcello Tonelli; Paul W Armstrong
Journal:  Circulation       Date:  2004-02-09       Impact factor: 29.690

9.  Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure.

Authors:  Adrian F Hernandez; Gregg C Fonarow; Li Liang; Sana M Al-Khatib; Lesley H Curtis; Kenneth A LaBresh; Clyde W Yancy; Nancy M Albert; Eric D Peterson
Journal:  JAMA       Date:  2007-10-03       Impact factor: 56.272

10.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

Authors:  S Yusuf; B Pitt; C E Davis; W B Hood; J N Cohn
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

View more
  24 in total

1.  Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure.

Authors:  Uptal D Patel; Melissa A Greiner; Gregg C Fonarow; Hemant Phatak; Adrian F Hernandez; Lesley H Curtis
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

2.  Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.

Authors:  Priyesh A Patel; Li Liang; Prateeti Khazanie; Bradley G Hammill; Gregg C Fonarow; Clyde W Yancy; Deepak L Bhatt; Lesley H Curtis; Adrian F Hernandez
Journal:  Circ Heart Fail       Date:  2016-07       Impact factor: 8.790

Review 3.  Kidney dysfunction and left ventricular assist device support: a comprehensive perioperative review.

Authors:  Samuel T Coffin; Dia R Waguespack; Nicholas A Haglund; Simon Maltais; Jamie P Dwyer; Mary E Keebler
Journal:  Cardiorenal Med       Date:  2015-01-09       Impact factor: 2.041

4.  Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function.

Authors:  Patrick H Pun; Shubin Sheng; Gillian Sanders; Adam D DeVore; Daniel Friedman; Gregg C Fonarow; Paul A Heidenreich; Clyde W Yancy; Adrian F Hernandez; Sana M Al-Khatib
Journal:  Am J Cardiol       Date:  2016-12-18       Impact factor: 2.778

5.  Characteristics and outcomes among heart failure patients with anemia and renal insufficiency with and without blood transfusions (public discharge data from California 2000-2006).

Authors:  David P Kao; Elma Kreso; Gregg C Fonarow; Mori J Krantz
Journal:  Am J Cardiol       Date:  2011-01       Impact factor: 2.778

6.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

Review 7.  Left Ventricular Assist Devices and the Kidney.

Authors:  Daniel W Ross; Gerin R Stevens; Rimda Wanchoo; David T Majure; Sandeep Jauhar; Harold A Fernandez; Massini Merzkani; Kenar D Jhaveri
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-25       Impact factor: 8.237

8.  Relationship between glycemic control and readmission rates in patients hospitalized with congestive heart failure during implementation of hospital-wide initiatives.

Authors:  Kathleen M Dungan; Kwame Osei; Haikady N Nagaraja; Dara P Schuster; Philip Binkley
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

9.  Adherence to the European Society of Cardiology (ESC) guidelines for chronic heart failure--a national survey of the cardiologists in Pakistan.

Authors:  Sana Shoukat; Saqib A Gowani; Ather M Taqui; Rameez Ul Hassan; Zain A Bhutta; Anum I Malik; Sajjad A Sherjeel; Quratulanne Sheheryar; Sajid H Dhakam
Journal:  BMC Cardiovasc Disord       Date:  2011-11-17       Impact factor: 2.298

10.  Feature and impact of guideline-directed medication prescriptions for heart failure with reduced ejection fraction accompanied by chronic kidney disease.

Authors:  Yung-Lung Chen; Chi-Ling Hang; Chien-Hao Su; Po-Jui Wu; Huang-Chung Chen; Hsiu-Yu Fang; Yen-Nan Fang; Cheng-I Cheng; Morgan Fu; Shyh-Ming Chen
Journal:  Int J Med Sci       Date:  2021-04-28       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.